Laddar...
Effect of Angiogenesis Inhibitor Bevacizumab on Survival in Patients with Cancer: A Meta-Analysis of the Published Literature
Bevacizumab is a recombinant humanized monoclonal antibody against vascular endothelial growth factor which has been used in conjunction with other anti-cancer agents in the treatment of patients with many cancers. It remains controversial whether bevacizumab can prolong survival in cancer patients....
Sparad:
| Huvudupphovsmän: | , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Public Library of Science
2012
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3335091/ https://ncbi.nlm.nih.gov/pubmed/22539986 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0035629 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|